candesartan has been researched along with Nephrolithiasis in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Nephrolithiasis: Formation of stones in the KIDNEY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Candesartan and sodium thiosulfate exhibited protective effect against nephrolithiasis." | 8.02 | Amelioration of lithiatic injury to renal tissue by candesartan and sodium thiosulfate in a rat model of nephrolithiasis. ( Ashmawy, HH; El-Ashmawy, NE; El-Bahrawy, HA; Khedr, EG, 2021) |
| "Candesartan and sodium thiosulfate exhibited protective effect against nephrolithiasis." | 4.02 | Amelioration of lithiatic injury to renal tissue by candesartan and sodium thiosulfate in a rat model of nephrolithiasis. ( Ashmawy, HH; El-Ashmawy, NE; El-Bahrawy, HA; Khedr, EG, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Ashmawy, NE | 1 |
| El-Bahrawy, HA | 1 |
| Ashmawy, HH | 1 |
| Khedr, EG | 1 |
1 other study available for candesartan and Nephrolithiasis
| Article | Year |
|---|---|
Amelioration of lithiatic injury to renal tissue by candesartan and sodium thiosulfate in a rat model of nephrolithiasis.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Ethylene Glycol; Kidney; Male; Nephrolithiasis; Protect | 2021 |